SAR441344
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR441344, covering 2025-09-16 to 2025-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) [Phase 2]